Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Infection and Immunity|December 24, 1998
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosaI Castagliuolo, M F Riegler, L Valenick, et al.
Gastroenterology|August 1, 1996
A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileumI Castagliuolo, J T LaMont, B Qiu, et al.
The American Journal of Physiology|February 12, 1998
CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritisA C Keates, I Castagliuolo, B Qiu, et al.
European Journal of Histochemistry : EJH|October 30, 2009
Neurotensin receptor 1 immunoreactivity in the peripheral ganglia and carotid bodyA Porzionato, V Macchi, A Amagliani, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 20, 2001
Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in ratsI Castagliuolo, K Karalis, L Valenick, et al.
The American Journal of Physiology|August 8, 1998
Colonic mucin release in response to immobilization stress is mast cell dependentI Castagliuolo, B K Wershil, K Karalis, et al.
International Journal of Pharmaceutics|November 11, 2008
Poly(ethylene glycol)-mesalazine conjugate for colon specific deliveryM Canevari, I Castagliuolo, P Brun, et al.
The American Journal of Physiology|August 1, 1997
IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileumI Castagliuolo, C P Kelly, B S Qiu, et al.
The Journal of Clinical Investigation|March 17, 1999
Neurotensin is a proinflammatory neuropeptide in colonic inflammationI Castagliuolo, C C Wang, L Valenick, et al.
Gut|February 12, 1998
Intravenous immunoglobulin therapy for severe Clostridium difficile colitisJ Salcedo, S Keates, C Pothoulakis, et al.
Pageof 5